Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 17:16 ET | Source: Bragar Eagel & Squire

JAYUD CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Jayud Stockholders to Contact the Firm Regarding Their Rights Before January 19th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jayud (JYD) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
January 06, 2026 17:04 ET | Source: Bragar Eagel & Squire

PRIMO BRANDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Primo Brands Corporation and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Primo Brands (PRMB) To Contact Him Directly To Discuss Their Options If you purchased or...
January 06, 2026 16:26 ET | Source: Bragar Eagel & Squire

FREEPORT URGENT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Freeport-McMoran Inc. and Encourages Investors to Contact the Firm Before January 12th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Freeport (FCX) To Contact Him Directly To Discuss Their Options If you purchased or...
January 06, 2026 15:21 ET | Source: Bragar Eagel & Squire

PERRIGO CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Encourages Perrigo Company plc Investors to Contact the Firm Before January 16th Regarding Their Rights

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Perrigo (PRGO) To Contact Him Directly To Discuss Their Options If you purchased or...
January 06, 2026 15:09 ET | Source: Bragar Eagel & Squire

SKYE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Skye Bioscience, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or acquired Skye...
January 06, 2026 14:45 ET | Source: Bragar Eagel & Squire

FERMI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Fermi, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fermi (FRMI) To Contact Him Directly To Discuss Their Options If you purchased or...
January 06, 2026 08:06 ET | Source: Bleichmar Fonti & Auld

Alexandria Real Estate Equities, Inc. (ARE) Impairment Charge Triggers Securities Fraud Class Action – Contact BFA Law before January 26 Court Deadline

Alexandria Real Estate Equities, Inc. (ARE) Impairment Charge Triggers Securities Fraud Class Action – Contact BFA Law before January 26 Court Deadline
January 05, 2026 18:25 ET | Source: Bragar Eagel & Squire

AGILON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Agilon Health, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or...
January 05, 2026 18:05 ET | Source: Bragar Eagel & Squire

CHARMING ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charming Medical Limited and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Charming (MCTA) To Contact Him Directly To Discuss Their Options If you purchased or...
January 05, 2026 16:51 ET | Source: Bragar Eagel & Squire

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

According to the lawsuit, Telix overstated prostate cancer drug progress and supply-chain quality, making its public statements misleading.